Of the above‐mentioned 28 genes, only one was upregulated in poor outcome patients, specifically MID1. Notably, 5 of 28 genes we identified have previously been reported to affect melanoma metastasis: CD82, NDRG2, RUNX3, CCL5 and HDC. This evidence concerns the gene CCL5 and melanoma.